US2023248043A1PendingUtilityA1
Nutritional composition
Est. expiryApr 10, 2032(~5.7 yrs left)· nominal 20-yr term from priority
A23L 33/30A23L 33/40A23L 33/12A23L 33/18A23L 33/17A23V 2002/00A23J 1/207A23L 33/10A23L 33/19A23L 33/125
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A nutritional composition having a total energy content of 67 kcal/100 ml or lower and including: a protein content which is 1.25 g/100 ml or lower, an energy content from protein of 7.2-8.4% of the total energy content of the nutritional composition, an energy content from fat which is at least 49% or more of the total energy content of the nutritional composition, a medium chain fatty acid content comprising 8 to 10 carbons which is less than 3 wt % of total amount of fatty acids, a sialic acid content of 10-25 mg/100 ml, a cholesterol content of 5-10 mg/100 ml, and a sphingomyelin content of 9-15 mg/100 ml is disclosed.
Claims
exact text as granted — not AI-modified1 - 27 . (canceled)
28 . A nutritional composition, as a ready-to-use product or a ready-to-use product reconstituted with water from a manufactured powder, wherein the total energy content is 67 kcal/100 ml or lower and the composition comprises;
a protein content which is 1.25 g/100 ml or lower, an energy content from protein of 7.2-8.4 percentage of the total energy content of the nutritional composition, an energy content from fat which is at least 49 percentage or more of the total energy content of the nutritional composition, a medium chain fatty acid content comprising 8 to 10 carbons which is less than 3 weight % of total amount of fatty acids, a sialic acid content of 10-25 mg/100 ml or higher, a cholesterol content of 5-10 mg/100 ml. a sphingomyelin content of 9-15 mg/100 ml.
29 . A method of treatment comprising administering to a subject in need thereof a nutritional composition according to claim 1 as an nutritional composition for achieving a development and/or growth pattern and/or morbidity more similar to breast-fed infants and/or regarding parameters which is any of growth, body composition wt % fat, cholesterol level, blood urea nitrogen (BUN), sialic acid in saliva, fasting insulin levels or decreased risk for obesity in childhood, insulin resistance, total thickness of intimate and media of the vessel wall of carotid communis, inflammation parameters, microbiological parameters, plasma amino acids, IGF-1, dietary intake.
30 . A method for producing a nutritional composition, comprising the steps;
providing ingredients per 1000 kg dry powder or per 8770 L ready to drink nutritional composition comprising; sweet whey solids between 32-40 kg/1000 kg dry powder composition or per 8770 L ready to drink nutritional composition; sodium caseinate between 4.6-5.7 kg/1000 kg dry powder composition or per 8770 L ready to drink nutritional composition; skim milk solids between 66-81 kg/1000 kg dry powder composition or per 8770 L ready to drink nutritional composition; whey protein concentrate solids rich in phospholipids between 47-58 kg/1000 kg dry powder composition or per 8770 L ready to drink nutritional composition; cream solids between 117-143 kg/1000 kg dry powder composition or per 8770 L ready to drink nutritional composition; and mixing the ingredients.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.